Cargando…

Hydrochlorothiazide does not increase furosemide's effects in end-stage renal disease

Diuretic therapy for the treatment of edema in patients with end-stage renal disease (ESRD) is unsatisfactory, and a combination of thiazide and loop diuretics may produce better clinical effects. To evaluate the influence of thiazide on loop diuretic therapy for ESRD, we performed a crossover study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huh, Wooseong, Oh, Ha-Young, Han, Jin Suk, Jang, In-Jin, Yim, Dong-Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Clinical Pharmacology and Therapeutics 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033539/ https://www.ncbi.nlm.nih.gov/pubmed/32095456 http://dx.doi.org/10.12793/tcp.2017.25.1.28

Ejemplares similares

Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome
por: Frățilă, Georgiana, et al.
Publicado: (2023)

Effects of diuretics furosemide and hydrochlorothiazide on CKD-MBD: A prospective randomized study
por: Vasco, Raquel F.V., et al.
Publicado: (2021)

Captopril Combined with Furosemide or Hydrochlorothiazide Affects Macrophage Functions in Mouse Contact Hypersensitivity Response
por: Bryniarski, Paweł, et al.
Publicado: (2021)

Association of furosemide or hydrochlorothiazide use with risk of atrial fibrillation post pacemaker implantation among elderly patients
por: Lin, Da-Wei, et al.
Publicado: (2021)

Does Exposure to Computed Tomography Contrast Media Increase Risk of End-Stage Renal Disease?
por: Lim, Eunsoo, et al.
Publicado: (2020)

Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome?
por: Na, K. Y., et al.
Publicado: (2001)

Early non-steady-state population pharmacokinetics of oral cyclosporine in renal transplant recipients
por: Baek, Hyunjeong, et al.
Publicado: (2014)

The presence of simple renal cysts is associated with an increased risk of albuminuria in young adults
por: Boo, Hyo Jin, et al.
Publicado: (2022)

Role of the Furosemide Stress Test in Renal Injury Prognosis
por: Coca, Armando, et al.
Publicado: (2020)

Chronic furosemide administration blunts renal BOLD magnetic resonance response to an acute furosemide stimulus in patients being evaluated for renal artery revascularization
por: Hall, Michael E, et al.
Publicado: (2013)

Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients
por: Destro, Maurizio, et al.
Publicado: (2010)

Predictive value of cardio-ankle vascular index for the risk of end-stage renal disease
por: Jeong, Jin Seon, et al.
Publicado: (2020)

Increased expression of renal TRPM6 compensates for Mg(2+) wasting during furosemide treatment
por: van Angelen, Annelies A., et al.
Publicado: (2012)

Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial
por: Sohn, Il Suk, et al.
Publicado: (2015)

Addition of Tolvaptan Compared With Increased Dose of Furosemide in Heart Failure Patients With Chronic Kidney Disease Under Furosemide Treatment
por: Tanaka, Toshiki, et al.
Publicado: (2018)

Erratum to: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial
por: Sohn, Il Suk, et al.
Publicado: (2016)

Pulmonary Calciphylaxis Associated with Acute Respiratory and Renal Failure Due to Cryptogenic Hypercalcemia: An Autopsy Case Report
por: Kim, Na Rae, et al.
Publicado: (2012)

Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension
por: Marfatia, Ravi, et al.
Publicado: (2012)

Development of model to predict end-stage renal disease after coronary artery bypass grafting: The ACHE score
por: Lee, Yeonhee, et al.
Publicado: (2019)

Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjects
por: Jung, Jihyun, et al.
Publicado: (2021)

Effectiveness of initiating treatment with valsartan/hydrochlorothiazide in patients with stage-1 or stage-2 hypertension
por: Zappe, D H, et al.
Publicado: (2010)

Colchicine-induced myoneuropathy in a cyclosporine-treated renal transplant recipient
por: Huh, Kyungmin, et al.
Publicado: (2013)

KP Index at the Initiation of Dialysis for Patients with End-stage Renal Disease
por: Hwang, Eui Won, et al.
Publicado: (2004)

The furosemide stress test to predict renal function after continuous renal replacement therapy
por: van der Voort, Peter HJ, et al.
Publicado: (2014)

Renal response and acid-base balance alterations during furosemide administration
por: Zazzeron, L, et al.
Publicado: (2013)

Apolipoprotein B is a risk factor for end-stage renal disease
por: Kwon, Soie, et al.
Publicado: (2020)

Comparison of Clinical Outcomes by Different Renal Replacement Therapy in Patients with End-Stage Renal Disease Secondary to Lupus Nephritis
por: Kang, Seok-Hui, et al.
Publicado: (2011)

Efficacy and Safety of Sugammadex for the Reversal of Rocuronium-Induced Neuromuscular Blockade in Patients with End-Stage Renal Disease: A Systematic Review and Meta-Analysis
por: Kim, Young-Sung, et al.
Publicado: (2021)

Telmisartan/hydrochlorothiazide-induced hepatotoxicity
por: Lorena, Marco, et al.
Publicado: (2015)

Hydrochlorothiazide: Hypocalcaemia: case report
Publicado: (2020)

Does Atrial Fibrillation Increase the Risk of Developing End-stage Renal Disease in Patients with Chronic Kidney Disease?
por: Suwanwongse, Kulachanya, et al.
Publicado: (2020)

Diuretic effect of co-administration of furosemide and albumin in comparison to furosemide therapy alone: An updated systematic review and meta-analysis
por: Lee, Tao Han, et al.
Publicado: (2021)

Epidermal Proteinase-Activated Receptor-2 Expression is Increased in End-Stage Renal Disease Patients with Pruritus: A Pilot Study
por: Moon, Sung Jin, et al.
Publicado: (2014)

Effects of levosimendan/furosemide infusion on Plasma Brain Natriuretic Peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients
por: Feola, Mauro, et al.
Publicado: (2011)

The impact of early and late acute rejection on graft survival in renal transplantation
por: Koo, Eun Hee, et al.
Publicado: (2015)

Sugammadex administration in patients with end-stage renal disease: a narrative review with recommendations
por: Oh, Seok Kyeong, et al.
Publicado: (2023)

An NMR crystallography investigation of furosemide
por: Zilka, Miri, et al.
Publicado: (2018)

Furosemide: No effect: case report
Publicado: (2020)

Use of Oral Furosemide in Hemodialysis
por: Siga, Esteban, et al.
Publicado: (2022)

Renal infarction caused by paradoxical embolism through a patent foramen ovale
por: Jeong, Hyemin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vmep1nr6hsrai62vtkbj29l8cg